• Site Search
  • News
  • Product
  • Zhejiang Medical Technology Development Co., Ltd.

    Headquartered in Hong Kong with its operational centers in Hangzhou and Shanghai, Winhealth Pharma Group is a China-focused portfolio and commercialization platform aiming to meet the unmet medical needs in the China market.


    Winhealth Pharma Group is dedicated to advancing Chinese pharmaceutical and healthcare industry and committed to introducing worldwide healthcare products and technologies into the Chinese market. We aim to provide diverse therapies, medical information communication channels, and other resources to the medical community and patients as well. 

    Since the establishment, Winhealth Pharma has been pursuing our mission of providing timely and effective clinical treatment for patients, adhering the core value of COLLABORATION, DEVOTION, CHALLENGE, AND OPEN, and dedicating in making the leading external innovation product portfolio and commercialization platform in China and its surrounding areas via our CDCO Model (Contract Development and Commercialization Organization). 

    Winhealth Pharmaceutical Group is  'dual-wheel driven' with our two business divisions, Established Pharmaceutical Division(EPD) and Innovative Therapeutics Division(ITD), of which the former covers brand-name drugs in five fields: respiratory diseases and anti-infection, cardiovascular, dermatology and medical aesthetics, urology and men's & women's health, while ITD focuses on innovative therapeutic with rare diseases at its core. 


    Winhealth has been growing fast because of its strong product import and brand operation capability, innovative product portfolio and abundant product pipeline, multinational pharmaceutical cooperation, powerful academic support and advantage of nation-wide leading industry scale. The group has est  long-term strategic partnership with well-known global and domestic pharmaceutical companies, such as Boehringer-Ingelheim, Roche, Pfizer, Bruschettini, Daiichi Sankyo, Kyowa Kirin, MERZ, Shionogi, Cheplapharm, Ferring, Novartis, Cumberland, Chiesi, PharmaCept, Alvogen, AsahiKASEI, Clinuvel, Immedica, TWi Biotechnology, etc.


    In addition, Winhealth has a nationwide and diversified marketing network that customizes academic-based marketing strategy and continuously covers the whole product life cycle. Winhealth has become a leading import joint venture supply chain and marketing service platform by establishing a four-in-one intelligent marketing system based on the Internet and digitization and applying abundant product resources and its nation-wide network.


    With passion and unremitting efforts, we will continue to build a leading solution provider and CDCO service platform through which innovative drugs can be commercialized and worldwide excellent pharmaceutical products can be introduced into China market. We are an ideal partner for global and domestic pharmaceutical companies to bring more and better medical products and therapeutic solutions to the China market. We will contribute to the development of China’s healthcare industry and the improvement of the life quality of patients.

    3rd Floor, Winhealth Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358    4008393773 ( Product Hotline )
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.